Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Carolyn Y. Muller"'
Autor:
Mara P. Steinkamp, Kimberly eKanigel-Winner, Suzy eDavies, Carolyn Y. Muller, Yong eZhang, Robert M. Hoffman, Abbas eShirinifard, Melanie eMoses, Yi eJiang, Bridget S eWilson
Publikováno v:
Frontiers in Oncology, Vol 3 (2013)
Ovarian cancer relapse is often characterized by metastatic spread throughout the peritoneal cavity with tumors attached to multiple organs. In this study, interaction of ovarian tumor cells with the peritoneal tumor microenvironment was evaluated in
Externí odkaz:
https://doaj.org/article/0ac4395774ed48b8a505f93cbb2ad60b
Autor:
Joyce F. Liu, Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher, David Cella, William P. Tew, Noelle G. Cloven, Carolyn Y. Muller, David P. Bender, Richard G. Moore, David P. Michelin, Steven E. Waggoner, Melissa A. Geller, Keiichi Fujiwara, Stacy D. D'Andre, Michael Carney, Angeles Alvarez Secord, Katherine M. Moxley, Michael A. Bookman
Publikováno v:
J Clin Oncol
PURPOSE Platinum-based chemotherapy is the standard of care for platinum-sensitive ovarian cancer, but complications from repeated platinum therapy occur. We assessed the activity of two all-oral nonplatinum alternatives, olaparib or olaparib/cediran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e9341979352c4a3d4d53e5247e5a4f
https://pubmed.ncbi.nlm.nih.gov/35290101
https://pubmed.ncbi.nlm.nih.gov/35290101
Autor:
Angela Wandinger-Ness, Laurie G. Hudson, Larry A. Sklar, Rytis Prekeris, Cristina Murray-Krezan, Elsa Romero, Teresa Rutledge, Sarah Adams, Carolyn Y. Muller, S. Ray Kenney, Yuna Guo
Cell characterization of primary ovarian cancer cells by immunofluorescence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594b025be104da56655283cec7e629a4
https://doi.org/10.1158/1535-7163.22506537
https://doi.org/10.1158/1535-7163.22506537
Autor:
Angela Wandinger-Ness, Laurie G. Hudson, Larry A. Sklar, Rytis Prekeris, Cristina Murray-Krezan, Elsa Romero, Teresa Rutledge, Sarah Adams, Carolyn Y. Muller, S. Ray Kenney, Yuna Guo
Patient information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3000f3b4492b38494f70960783688c91
https://doi.org/10.1158/1535-7163.22506528
https://doi.org/10.1158/1535-7163.22506528
Autor:
Angela Wandinger-Ness, Laurie G. Hudson, Larry A. Sklar, Rytis Prekeris, Cristina Murray-Krezan, Elsa Romero, Teresa Rutledge, Sarah Adams, Carolyn Y. Muller, S. Ray Kenney, Yuna Guo
Legends for the supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e46a5ca7e1bcac90351bc604150e2047
https://doi.org/10.1158/1535-7163.22506543.v1
https://doi.org/10.1158/1535-7163.22506543.v1
Autor:
Angela Wandinger-Ness, Laurie G. Hudson, Larry A. Sklar, Rytis Prekeris, Cristina Murray-Krezan, Elsa Romero, Teresa Rutledge, Sarah Adams, Carolyn Y. Muller, S. Ray Kenney, Yuna Guo
Method of immunofluorescence for the ovarian cancer cell identification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5013dbe8fc8ed75e5140246eae4c7a
https://doi.org/10.1158/1535-7163.22506531
https://doi.org/10.1158/1535-7163.22506531
Autor:
Angela Wandinger-Ness, Laurie G. Hudson, Larry A. Sklar, Rytis Prekeris, Cristina Murray-Krezan, Elsa Romero, Teresa Rutledge, Sarah Adams, Carolyn Y. Muller, S. Ray Kenney, Yuna Guo
Biochemical properties of Cdc42 and Rac1 nucleotide binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf06cbe59121c72dd8d16b889a53dee
https://doi.org/10.1158/1535-7163.22506525
https://doi.org/10.1158/1535-7163.22506525
Autor:
Angela Wandinger-Ness, Laurie G. Hudson, Larry A. Sklar, Rytis Prekeris, Cristina Murray-Krezan, Elsa Romero, Teresa Rutledge, Sarah Adams, Carolyn Y. Muller, S. Ray Kenney, Yuna Guo
Cdc42 (cell division control protein 42) and Rac1 (Ras-related C3 botulinum toxin substrate 1) are attractive therapeutic targets in ovarian cancer based on established importance in tumor cell migration, adhesion, and invasion. Despite a predicted b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e273c446be552dd15d3f436073544021
https://doi.org/10.1158/1535-7163.c.6538428.v1
https://doi.org/10.1158/1535-7163.c.6538428.v1
Autor:
Laurie G. Hudson, Angela Wandinger-Ness, Carolyn Y. Muller, Lesley Lomo, Huining Kang, Charles L. Wiggins, Edward Bedrick, Larry A. Sklar, Tudor I. Oprea, Elsa Romero, Teresa Rutledge, Sarah F. Adams, Linda Cook, S. Ray Kenney, Yuna Guo
Supplemental Figure S3. Racemic distribution of clinical drug.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6258d21df36efd69e49527489c4b32bf
https://doi.org/10.1158/1078-0432.22456116
https://doi.org/10.1158/1078-0432.22456116
Autor:
Laurie G. Hudson, Angela Wandinger-Ness, Carolyn Y. Muller, Lesley Lomo, Huining Kang, Charles L. Wiggins, Edward Bedrick, Larry A. Sklar, Tudor I. Oprea, Elsa Romero, Teresa Rutledge, Sarah F. Adams, Linda Cook, S. Ray Kenney, Yuna Guo
Purpose: We previously identified the R-enantiomer of ketorolac as an inhibitor of the Rho-family GTPases Rac1 and Cdc42. Rac1 and Cdc42 regulate cancer-relevant functions, including cytoskeleton remodeling necessary for tumor cell adhesion and migra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3324acd674882a1c07e80040d7159356
https://doi.org/10.1158/1078-0432.c.6523206
https://doi.org/10.1158/1078-0432.c.6523206